stock
BBNX · Beta Bionics, Inc.
What Beta Bionics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live BBNX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on BBNX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 44,989,688 as of 2026-07-27 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- 58.3%
- Operating
- -69.8%
- Net
- -61.3%
Returns
- ROE
- -28.5%
- ROA
- -25.0%
Health
- Current ratio
- 8.9x
- Debt/equity
- —
Deep value
- NCAV
- $195.01M
- NCAV per share
- $4.33
- Price/NCAV
- Locked
- NNWC
- $33.80M
- NNWC per share
- $0.75
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $32.01M | $18.90M | -$25.58M | -$23.40M | 10-Q filed 2026-07-29 |
| 2026-03-31 | $27.63M | $16.44M | -$24.27M | -$21.89M | 10-Q filed 2026-04-21 |
| 2025-12-31 | $32.12M | $18.94M | -$16.12M | -$13.47M | 10-K filed 2026-02-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-09-30 | $27.25M | $15.12M | -$17.04M | -$14.21M | 10-Q filed 2025-10-28 |
| 2025-06-30 | $23.24M | $12.50M | -$19.87M | -$16.87M | 10-Q filed 2026-07-29 |
| 2025-03-31 | $17.64M | $8.97M | -$18.64M | -$28.66M | 10-Q filed 2026-04-21 |
| 2024-12-31 | $20.44M | $11.69M | -$13.04M | -$18.11M | 10-K filed 2026-02-24 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | $16.70M | $8.91M | -$10.98M | -$9.74M | 10-Q filed 2025-10-28 |
- Assets
- $292.39M
- Equity
- $256.37M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $100.25M | -$71.68M | -$73.20M | -$56.22M |
| 2024-12-31 | $65.12M | -$45.25M | -$54.76M | -$51.67M |
| 2023-12-31 | $11.99M | -$35.85M | -$44.10M | -$32.85M |
Company filings
since Tue Feb 24 · 2 offering filings in 12 months
events
5% owners ()
Farallon Capital Management, L.L.C.
Stake update
Divisadero Street Capital Management, LP
Passive stake
Eventide Asset Management, LLC
Stake update
RTW Investments, LP
Stake update
Zone Healthcare Holdings, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Hopman Mark
Chief Commercial Officer
Sale$7,015Oct 5, 5:11 PM ET
Jones Christy
Director
Sale$147,890Sep 23, 5:40 PM ET
Hopman Mark
Chief Commercial Officer
Sale$664,550Sep 18, 7:51 PM ET
Hopman Mark
Chief Commercial Officer
Sale$619,640Sep 17, 4:15 PM ET
Mensinger Mike
Chief Product Officer
Sale$58,300Sep 17, 4:15 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named BBNX, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about BBNX.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on BBNX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the BBNX board